How many institutions held AQST - Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value in Q2 2020?

56 institutional investors reported AQST - Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value for Q2 2020. Use the holders table for investor-level position and value details.

Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST)

Q: What does CUSIP 03843E104 represent in this 13F holders report?

CUSIP 03843E104 is the security identifier for AQST - Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value used to aggregate holder disclosures.

CUSIP: 03843E104

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class: Equity / Common Stock, $0.001 par value
Shares outstanding: 120,192,308
Total 13F shares: 18,511,676
Share change: +2,553,086
Total reported value: $89,959,616
Put/Call ratio: 87%
Price per share: $4.86
Number of holders: 56
Value change: +$16,355,927
Number of buys: 39
Number of sells: 18

Quarterly Holders Quick Answers

What is CUSIP 03843E104?
CUSIP 03843E104 identifies AQST - Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2020
Previous quarter: Q1 2020

Recent filing periods for CUSIP 03843E104:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of AQST - Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Bratton Capital Management, L.P.	13F	Company	9.6%	11,503,294	$25,192,000	—	31 Mar 2020	13F
VANGUARD GROUP INC	13F	Company	0.52%	626,713	$1,373,000	—	31 Mar 2020	13F
DG Capital Management, LLC	13F	Company	0.45%	546,249	$1,196,000	—	31 Mar 2020	13F
Bracebridge Capital, LLC	13F	Company	0.36%	428,571	$1,000,000	—	31 Mar 2020	13F
JPMORGAN CHASE & CO	13F	Company	0.34%	413,962	$907,000	—	31 Mar 2020	13F
Eversept Partners, LP	13F	Company	0.25%	300,000	$657,000	—	31 Mar 2020	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.24%	294,051	$644,000	—	31 Mar 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.2%	237,394	$520,000	—	31 Mar 2020	13F
D. E. Shaw & Co., Inc.	13F	Company	0.18%	214,222	$469,000	—	31 Mar 2020	13F
BlackRock Finance, Inc.	13F	Company	0.18%	211,462	$463,000	—	31 Mar 2020	13F
CANADA PENSION PLAN INVESTMENT BOARD	13F	Company	0.15%	175,000	$383,000	—	31 Mar 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.12%	149,089	$326,000	—	31 Mar 2020	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.08%	98,610	$216,000	—	31 Mar 2020	13F
Brandywine Global Investment Management, LLC	13F	Company	0.07%	89,429	$196,000	—	31 Mar 2020	13F
WEDBUSH SECURITIES INC	13F	Company	0.07%	86,766	$190,000	—	31 Mar 2020	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.07%	80,500	$176,000	—	31 Mar 2020	13F
Oak Grove Capital LLC	13F	Company	0.06%	70,400	$154,000	—	31 Mar 2020	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.05%	58,473	$128,000	—	31 Mar 2020	13F
NORTHERN TRUST CORP	13F	Company	0.04%	47,304	$104,000	—	31 Mar 2020	13F
BANCO BILBAO VIZCAYA ARGENTARIA, S.A.	13F	Company	0.03%	40,512	$88,000	—	31 Mar 2020	13F
True North Advisors, LLC	13F	Company	0.03%	32,295	$70,000	—	31 Mar 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.02%	25,906	$57,000	—	31 Mar 2020	13F
Tower Research Capital LLC (TRC)	13F	Company	0.02%	21,622	$47,000	—	31 Mar 2020	13F
MORGAN STANLEY	13F	Company	0.02%	19,714	$43,000	—	31 Mar 2020	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.02%	19,400	$42,000	—	31 Mar 2020	13F
UBS Group AG	13F	Company	0.02%	19,188	$42,000	—	31 Mar 2020	13F
Creative Planning	13F	Company	0.01%	18,000	$39,000	—	31 Mar 2020	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.01%	17,300	$38,000	—	31 Mar 2020	13F
Squarepoint Ops LLC	13F	Company	0.01%	16,425	$36,000	—	31 Mar 2020	13F
Spark Investment Management LLC	13F	Company	0.01%	15,300	$33,000	—	31 Mar 2020	13F
Qube Research & Technologies Ltd	13F	Company	0.01%	13,974	$31,000	—	31 Mar 2020	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	0.01%	13,660	$30,000	—	31 Mar 2020	13F
ROYAL BANK OF CANADA	13F	Company	0.01%	13,360	$29,000	—	31 Mar 2020	13F
FRONTIER INVESTMENT MGMT CO	13F	Company	0.01%	11,000	$24,000	—	31 Mar 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.01%	10,622	$23,000	—	31 Mar 2020	13F
BANK OF MONTREAL /CAN/	13F	Company	0.01%	10,009	$19,000	—	31 Mar 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.01%	8,500	$19,000	—	31 Mar 2020	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0%	4,980	$11,000	—	31 Mar 2020	13F
MEEDER ASSET MANAGEMENT INC	13F	Company	0%	3,618	$8,000	—	31 Mar 2020	13F
CITIGROUP INC	13F	Company	0%	3,574	$8,000	—	31 Mar 2020	13F
SIMPLEX TRADING, LLC	13F	Company	0%	1,058	$2,000	—	31 Mar 2020	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0%	45	$99	—	31 Mar 2020	13F

Institutional Holders of Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST) as of Q2 2020

As of 30 Jun 2020, Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST) was held by 56 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,511,676 shares. The largest 10 holders included Bratton Capital Management, L.P., PERCEPTIVE ADVISORS LLC, BlackRock Inc., VANGUARD GROUP INC, Bracebridge Capital, LLC, STATE STREET CORP, D. E. Shaw & Co., Inc., GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, and Squarepoint Ops LLC. This page lists 56 institutional shareholders reporting positions in this security for the Q2 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders

Q2 2020 holders

Holder diff

Investor	Q1 2020 Shares	Q2 2020 Shares	Share Diff	Share Chg %	Q1 2020 Value $	Q2 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.